Connect with us

Digital Health

Accenture, Salesforce Partner on Generative AI for Life Sciences Companies

What You Should Know:  – Accenture and Salesforce are investing in the development of Salesforce Life Sciences Cloud, focusing on innovation, assets,…

Published

on

This article was originally published by HIT Consultant
Accenture, Salesforce Partner on Generative AI for Life Sciences Companies

What You Should Know: 

Accenture and Salesforce are investing in the development of Salesforce Life Sciences Cloud, focusing on innovation, assets, and accelerators powered by data and artificial intelligence (AI) to help life sciences companies create sustainable value and drive growth.

– Building on their generative AI collaboration, Accenture and Salesforce will leverage their joint generative AI acceleration hub to develop new solutions and use cases for Salesforce Life Sciences Cloud.

Salesforce Data Cloud and Einstein AI

According to Accenture Research, 58% of life sciences companies consider the accelerated adoption of data and analytics capabilities as a top investment priority. As part of the collaboration, both will use Salesforce Data Cloud and Einstein AI, Salesforce’s AI technology, to enhance productivity and transform healthcare professional and patient experiences. 

The patient services Health Cloud assessment framework generates insights and a value case for Salesforce Life Sciences Cloud. The pharmaceutical Data Cloud and Einstein AI accelerator leverages generative AI to provide a holistic view of provider and patient data and suggest the most important messages for patient interactions.

Future Development

Accenture will continue to develop complementary tools and methodologies to help clients test and pilot the new capabilities of Salesforce Life Sciences Cloud.

artificial intelligence


pharmaceutical

Digital Health

Keep it Short

By KIM BELLARD OK, I admit it: I’m on Facebook. I still use Twitter – whoops, I mean X. I have an Instagram account but don’t think I’ve ever posted….

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading
Digital Health

Seattle startup Olamedi building platform to automate health clinic communications

A new Seattle startup led by co-founders with experience in health tech is aiming to automate communication processes for healthcare clinics with its software…

Continue Reading

Trending